ORS-1006

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameORS-1006
Drug Alias NameORS-1006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors
TargetsDual-specificity tyrosine-phosphorylation regulated kinase 1A
Therapy Area/IndicationsDown SyndromeAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArrien Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArrien Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsDown SyndromeAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A